Cargando…

Epigenetic Mediation of AKT1 rs1130233’s Effect on Delta-9-Tetrahydrocannabinol-Induced Medial Temporal Function during Fear Processing

High doses of delta-9-tetrahydrocannabinol (THC), the main psychoactive component of cannabis, have been shown to have anxiogenic effects. Additionally, THC effects have been shown to be modulated by genotype, including the single nucleotide polymorphism (SNP) rs1130233 at the protein kinase AKT1 ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blest-Hopley, Grace, Colizzi, Marco, Prata, Diana, Giampietro, Vincent, Brammer, Michael, McGuire, Philip, Bhattacharyya, Sagnik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471665/ https://www.ncbi.nlm.nih.gov/pubmed/34573260 http://dx.doi.org/10.3390/brainsci11091240

Ejemplares similares

S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE
por: Colizzi, Marco, et al.
Publicado: (2018)

Descriptive Psychopathology of the Acute Effects of Intravenous Delta-9-Tetrahydrocannabinol Administration in Humans
por: Colizzi, Marco, et al.
Publicado: (2019)

Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
por: Blest-Hopley, Grace, et al.
Publicado: (2020)

Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis
por: Colizzi, Marco, et al.
Publicado: (2019)

A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis
por: Davies, Cathy, et al.
Publicado: (2020)

Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition
por: Colizzi, Marco, et al.
Publicado: (2017)

Regular cannabis use is associated with altered activation of central executive and default mode networks even after prolonged abstinence in adolescent users: Results from a complementary meta-analysis
por: Blest-Hopley, Grace, et al.
Publicado: (2019)

A Systematic Review of Human Neuroimaging Evidence of Memory-Related Functional Alterations Associated with Cannabis Use Complemented with Preclinical and Human Evidence of Memory Performance Alterations
por: Blest-Hopley, Grace, et al.
Publicado: (2020)

Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors
por: Bhattacharyya, Sagnik, et al.
Publicado: (2017)

Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in people at clinical high risk for psychosis: a preliminary report
por: Davies, Cathy, et al.
Publicado: (2021)

T99. LONG-TERM CANNABIS USE ASSOCIATED WITH ALTERED FUNCTIONING DURING VERBAL LEARNING
por: Blest-Hopley, Grace, et al.
Publicado: (2018)

Disrupted parahippocampal and midbrain function underlie slower verbal learning in adolescent-onset regular cannabis use
por: Blest-Hopley, Grace, et al.
Publicado: (2019)

S152. CANNABIDIOL INDUCED MODULATION OF MEDIOTEMPORAL ACTIVITY DURING A VERBAL MEMORY TASK IN FIRST-EPISODE PSYCHOSIS
por: O’Neill, Aisling, et al.
Publicado: (2018)

Cannabidiol modulation of hippocampal glutamate in early psychosis
por: O’Neill, Aisling, et al.
Publicado: (2021)

O5.2. CBD MODULATION OF HIPPOCAMPAL GLUTAMATE IN PSYCHOSIS
por: O’Neill, Aisling, et al.
Publicado: (2020)

Delta-8 Tetrahydrocannabinol Product Impurities
por: Ray, Colleen L., et al.
Publicado: (2022)

Cannabis: Neuropsychiatry and Its Effects on Brain and Behavior
por: Colizzi, Marco, et al.
Publicado: (2020)

Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women
por: Wardle, Margaret C., et al.
Publicado: (2022)

Acute Effects of Delta-9-Tetrahydrocannabinol on Performance Monitoring in Healthy Volunteers
por: Spronk, Desirée, et al.
Publicado: (2011)

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
por: Colizzi, Marco, et al.
Publicado: (2020)

Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis
por: Wilson, Robin, et al.
Publicado: (2019)

Effect of Delta-9-Tetrahydrocannabinol on Mouse Resistance to Systemic Candida albicans Infection
por: Blumstein, Gideon W., et al.
Publicado: (2014)

A Conversion of Oral Cannabidiol to Delta9-Tetrahydrocannabinol Seems Not to Occur in Humans
por: Nahler, Gerhard, et al.
Publicado: (2017)

Glucocorticoids, Stress and Delta-9 Tetrahydrocannabinol (THC) during Early Embryonic Development
por: Kuzma-Hunt, Alexander G., et al.
Publicado: (2021)

Effects of Delta-9 Tetrahydrocannabinol (THC) on Oocyte Competence and Early Embryonic Development
por: Misner, Megan J., et al.
Publicado: (2021)

Transcriptional Alterations Induced by Delta-9 Tetrahydrocannabinol in the Brain and Gonads of Adult Medaka
por: Vassall, Marlee, et al.
Publicado: (2023)

T145. EFFECTS OF CANNABIDIOL ON EMOTION PROCESSING IN PSYCHOSIS RISK: AN FMRI INVESTIGATION
por: Davies, Cathy, et al.
Publicado: (2020)

Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence
por: Bortoletto, Riccardo, et al.
Publicado: (2022)

Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro
por: Medveczky, Maria M, et al.
Publicado: (2004)

Disposable screen printed sensor for the electrochemical detection of delta-9-tetrahydrocannabinol in undiluted saliva
por: Wanklyn, Ceri, et al.
Publicado: (2016)

Delta-9-tetrahydrocannabinol, neural oscillations above 20 Hz and induced acute psychosis
por: Nottage, Judith F., et al.
Publicado: (2014)

Psychoactive drugs and false memory: comparison of dextroamphetamine and delta-9-tetrahydrocannabinol on false recognition
por: Ballard, Michael E., et al.
Publicado: (2011)

Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the “weed,” a pharmacodynamic discussion
por: Boggs, Douglas Lee, et al.
Publicado: (2016)

Antitumor Effects of Delta (9)-Tetrahydrocannabinol and Cannabinol on Cholangiocarcinoma Cells and Xenograft Mouse Models
por: Leelawat, Surang, et al.
Publicado: (2022)

Analgesia by intrathecal delta-9-tetrahydrocannabinol is dependent on Cav3.2 calcium channels
por: Gadotti, Vinicius de Maria, et al.
Publicado: (2023)

Self-reported adverse events associated with ∆(8)-Tetrahydrocannabinol (Delta-8-THC) Use
por: Leas, Eric C., et al.
Publicado: (2023)

Editorial: The Endocannabinoid System: Filling the Translational Gap Between Neuroscience and Psychiatry
por: De Gregorio, Danilo, et al.
Publicado: (2021)

Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia
por: Ahmed, Amir I. A., et al.
Publicado: (2015)

Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
por: Morgan, Celia J. A., et al.
Publicado: (2018)

MON-010 Effects of Delta-9-Tetrahydrocannabinol (THC) on Oocyte Competence and Early Embryonic Development
por: Misner, Megan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rfes6s31bv55rqoqm26lenka1c